Potential new avenues of treatment for chronic rhinosinusitis: An anti-inflammatory approach

Otolaryngologic Clinics of North America

Volumn 38, Issue 6, 2005, Pages 1351-1365

  Statham, Melissa McCarty ^a   Seiden, Allen ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; BICARBONATE; CLARITHROMYCIN; CORTICOSTEROID; DESLORATADINE; FLUTICASONE; GAMMA INTERFERON; IMATINIB; IMMUNOMODULATING AGENT; INTERLEUKIN 5 ANTIBODY; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCETIRIZINE; LYSINE ACETYLSALICYLATE; MACROLIDE; MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; PREDNISOLONE; RAGWEED ANTIGEN; ROXITHROMYCIN; SODIUM CHLORIDE; STEROID; ZAFIRLUKAST; ZILEUTON;

ALLERGIC RHINITIS; ALLERGY; ANOSMIA; ANTIINFLAMMATORY ACTIVITY; ASTHMA; ATOPY; AUTOIMMUNE DISEASE; CHRONIC SINUSITIS; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG PENETRATION; HEALTH CARE COST; HUMAN; HYPEREOSINOPHILIA; IMMUNOTHERAPY; INJECTION SITE REACTION; LOW DRUG DOSE; NONHUMAN; NOSE CONGESTION; NOSE POLYP; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; RHINOSINUSITIS; SEDATION; SIDE EFFECT; SINUSITIS; SKIN MANIFESTATION;

ADMINISTRATION, INTRANASAL; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIFUNGAL AGENTS; CHRONIC DISEASE; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; INFLAMMATION MEDIATORS; LEUKOTRIENE ANTAGONISTS; MACROLIDES; RHINITIS; SINUSITIS;

EID: 28444492704     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2005.08.005     Document Type: Review

References (74)

1. S.H. Shin, J.U. Ponikau, and D.A. Sherris Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi J Allergy Clin Immunol 114 2004 1369 1375
2. S.C. Marks Acute sinusitis in the rabbit model: histologic analysis Laryngoscope 108 1998 320 325
3. C.J. Abraham, B.T. Faddis, and R.A. Chole Chronic bacterial rhinosinusitis: description of a mouse model Arch Otolaryngol Head Neck Surg 127 6 2001 657 664
4. J. Bousquet, W. Jacquot, and A.M. Vignola Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol 113 2004 43 49
5. J. Corren, B.E. Manning, and S.F. Thompson Rhinitis therapy and the prevention of hospital care for asthma: a case-control study J Allergy Clin Immunol 113 2004 415 419
6. R. Medzhitov, and C. Janeway Jr. Innate immunity N Engl J Med 343 2000 338 344
7. S.L. Swain Helper T cell differentiation Curr Opin Immunol 11 1999 180 185
8. M. Kuehnemund, C. Ismail, and J. Brieger Untreated chronic rhinosinusitis: a comparison of symptoms and mediator profiles Laryngoscope 114 3 2004 561 565
9. J.M. Bernstein, M. Ballow, and G. Rich Lymphocyte subpopulations and cytokines in nasal polyps: is there a local immune system in the nasal polyp? Otolaryngol Head Neck Surg 130 5 2004 526 535
10. F. Bolard, P. Gosset, and C. Lamblin Cell and cytokine profiles in nasal secretions from patients with nasal polyposis: effects of topical steroids and surgical treatment Allergy 56 2001 333 338
11. C. Bachert, P. Gevaert, and G. Holtappels Total and specific IgE in nasal polyps is related to local eosinophilic inflammation J Allergy Clin Immunol 107 2001 606 614
12. E.D. Wright, S. Frenkiel, and K. Al-Ghamdi Interleukin-4, interleukin-5, and granulocyte-macrophage colony stimulating factor receptor expression in chronic sinusitis and response to topical steroids Otolaryngol Head Neck Surg 118 4 1998 490 495
13. J.U. Ponikau, D.A. Sherris, and H. Kita Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis J Allergy Clin Immunol 110 2002 862 866
14. A. Ricchetti, B.N. Landis, and A. Maffioli Effect of anti-fungal lavage with amphotericin B on nasal polyposis J Laryngol Otol 116 2002 261 263
15. J.U. Ponikau, D.A. Sherris, and A. Weaver Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial J Allergy Clin Immunol 115 1 2005 125 131
16. M. Weschta, D. Rimek, and M. Formanek Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial J Allergy Clin Immunol 113 2004 1122 1128
17. A. Cervin, O. Kalm, and P. Sandkull One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide Otolaryngol Head Neck Surg 126 2002 481 489
18. M. Hashiba, and S. Baba Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis Acta Otolaryngol Suppl 525 1996 73 78
19. S. Kawasaki, H. Takizawa, and T. Ohtoshi Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro Antimicrob Agents Chemother 42 1998 1499 1502
20. B. Wallwork, W. Coman, and F. Feron Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis Laryngoscope 112 2002 1827 1830
21. J. Tamaoki The effects of macrolides on inflammatory cells Chest 125 2004 41S 50S
22. H. Lin, C. Wang, and C. Liu Erythromycin inhibits beta2-integrins (CD11b/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils Respir Med 94 2000 654 660
23. T. Miyanohara, M. Ushikai, and S. Matsune Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts Laryngoscope 110 2000 126 131
24. B. Wallwork, W. Coman, and A. Mackay-Sim Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis Laryngoscope 114 2004 286 290
25. S. Konno, K. Asano, and M. Kurokawa Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo Int Arch Allergy Immunol 105 1994 308 316
26. H. Amayasu, S. Yoshida, and S. Ebana Clarithromycin suppresses bronchial hyper-responsiveness associated with eosinophilic inflammation in patients with asthma Ann Allergy Asthma Immunol 84 2000 594 598
27. O. Culic, V. Erakovic, and M. Parnham Anti-inflammatory effect of macrolide antibiotics Eur J Pharmacol 428 2001 209 229
28. H. Suzuki, K. Ikeda, and R. Honma Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy ORL J Otorhinolaryngol Relat Spec 62 2000 121 127
29. L. Borish The role of leukotrienes in upper and lower airway inflammation and the implications for treatment Ann Allergy Asthma Immunol 88 2002 16 22
30. F. Braccioni, S.C. Dorman, and P.M. O'Byrne The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects J Allergy Clin Immunol 110 2002 96 101
31. T.F. Reiss, P. Chervinsky, and R.J. Dockhorn Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma Arch Intern Med 158 1998 1213 1220
32. E. Pizzichini, J.A. Leff, and T.F. Reiss Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial Eur Respir J 14 1999 12 18
33. S.M. Parnes, and A.V. Churna Acute effects of antileukotrienes on sinonasal polyposis and sinusitis Ear Nose Throat J 79 2000 18 21
34. B. Dahlen, E. Nizankowska, and A. Szczeklik Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics Am J Respir Crit Care Med 157 1998 1187 1194
35. A.R. Sousa, A. Parikh, and G. Scadding Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis N Engl J Med 347 2002 1493 1499
36. A. Szczeklik, and D.D. Stevenson Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management J Allergy Clin Immunol 111 2003 913 921
37. A.R. Talbot, T.M. Herr, and D.S. Parsons Mucociliary clearance and buffered hypertonic saline solution Laryngoscope 107 1997 500 503
38. W.M. Boek, K. Graamans, and H. Natzijl Nasal mucociliary transport: new evidence for a key role of ciliary beat frequency Laryngoscope 112 2002 570 573
39. W.M. Boek, N. Keleş, and K. Graamans Physiologic and hypertonic saline solutions impair ciliary activity in vitro Laryngoscope 109 1999 396 399
40. L.T. Tomooka, C. Murphy, and T.M. Davidson Clinical study and literature review of nasal irrigation Laryngoscope 110 2000 1189 1193
41. D. Shoseyov, H. Bibi, and P. Shai Treatment with hypertonic saline versus normal saline wash of pediatric chronic rhinosinusitis J Allergy Clin Immunol 101 1998 602 605
42. B.J. Ferguson Allergic rhinitis: options for pharmacotherapy and immunotherapy Postgrad Med 101 1997 117 126
43. J.J. Homer, R.J. England, and A.D. Wilde The effect of pH of douching solutions on mucociliary clearance Clin Otolaryngol 24 1999 312 315
44. C.L. Brown, and S.M. Graham Nasal irrigations: good or bad? Curr Opin Otolaryngol Head Neck Surg 12 2004 9 13
45. W.C. Vaughan, and G. Carvalho Use of nebulized antibiotics for acute infections in chronic sinusitis Otolaryngol Head Neck Surg 127 2002 558 568
46. T.R. Miller, H.R. Muntz, and M.E. Gilbert Comparison of topical medication delivery systems after sinus surgery Laryngoscope 114 2004 201 204
47. J.M. Wiener, M.J. Abramson, and R.M. Puy Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomized controlled trials BMJ 317 1998 1624 1629
48. G. Scadding Medical management of chronic rhinosinusitis Immunol Allergy Clin North Am 24 2004 103 118
49. E.O. Meltzer, H.A. Orgel, and J.W. Backhaus Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis J Allergy Clin Immunol 92 1993 812 823
50. R.J. Dolor, D.L. Witsell, and A.S. Hellkamp Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis: the CAFFS Trial: a randomised controlled trial JAMA 286 2001 3097 3105
51. E.O. Meltzer, B.L. Charous, and W.W. Busse Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray: the Nasonex Sinusitis Group J Allergy Clin Immunol 106 2000 630 637
52. V. Lund, S. Black, and Z.S. Laszlo Budesonide aqueous nasal spray (BANS, Rhinocort aqua) is effective as monotherapy in stable patients with chronic rhinosinusitis J Allergy Clin Immunol 109 2002 S290
53. T. Lildholdt, H. Runderantz, and M. Bende Glucocorticoid treatment for nasal polyps: the use of topical budesonide powder, intramuscular betamethasone and surgical treatment Arch Otolaryngol Head Neck Surg 123 1997 595 600
54. A.A.C. Aukema, P.G.H. Mulder, and W.J. Fokkens Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery J Clin Allergy Clin Immunol 115 2005 1017 1023
55. K. Holmberg, S. Juliusson, and B. Balder Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis Ann Allergy Asthma Immunol 78 1997 270 276
56. J. Ruhno, B. Andersson, and J. Denburg A double-blind comparison of intranasal budesonide with placebo for nasal polyposis J Allergy Clin Immunol 86 1990 946 953
57. P. Keith, J. Nieminen, and K. Hollingworth Efficacy and tolerability of fluticasone propionate nasal drops 400mgs once daily compared with placebo for the treatment of bilateral polyposis in adults Clin Exp Allergy 30 2000 1460 1468
58. M. Pentila, P. Poulsen, and K. Hollingworth Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 mg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled, randomised study in adult patients Clin Exp Allergy 30 2000 94 102
59. S.J. Till, J.N. Francis, and K. Nouri-Aria Mechanisms of immunotherapy J Allergy Clin Immunol 113 2004 1025 1034
60. F.E. Simons, Y. Skikishima, G. Van Nest, and K.T. HayGlass Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA J Allergy Clin Immunol 113 2004 1144 1151
61. M.K. Tulic, P.O. Fiset, and P. Christodoulopoulos Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response J Allergy Clin Immunol 113 2004 235 241
62. B.A. Bassichis, B.F. Marple, and R.L. Mabry Use of immunotherapy and previously treated patients with allergic fungal sinusitis Otolaryngol Head Neck Surg 125 2001 487 490
63. C. Bachert, J. Bousquet, and G.W. Canonica Levocetirizine improves quality of life and reduces cost in long-term management of persistent allergic rhinitis J Allergy Clin Immunol 114 2004 838 844
64. C. Deruaz, A. Leimgruber, and M. Berney Levocetirizine better protects than desloratadine in a nasal provocation with allergen J Allergy Clin Immunol 113 2004 669 676
65. H. Lin, K.M. Boesel, and D.T. Griffith Omalizumab rapidly decreases nasal allergic response and RceRI on basophils J Allergy Clin Immunol 113 2004 297 302
66. M.J. Leckie, A. ten Brinke, and J. Khan Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic process Lancet 356 2000 2144 2148
67. P.T. Flood-Page, A.N. Menzies-Gow, and A.B. Kay Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in the asthmatic airway Am J Respir Crit Care Med 167 2003 199 204
68. B.S. Bochner Verdict in the case of therapies versus eosinophils: the jury is still out J Allergy Clin Immunol 113 2004 3 9
69. M.J. Koury, J.H. Newman, and J.J. Murray Reversal of hypereosinophilic syndrome and lymphomatoid papulosis with mepolizumab and imatinib Am J Med 115 2003 587 589
70. S.B. Tanner, C.E. Arthur, and J.J. Murray Imatinib mesylate treatment for eosinophilic gastroenteritis Clin Immunol Suppl 1 2003 85
71. H. Jyonouchi, S. Sun, H. Le, and F. Rimell Evidence of dysregulated cytokine production by sinus lavage and peripheral blood mononuclear cells in patients with treatment-resistant chronic rhinosinusitis Arch Otolarygol Head Neck Surg 127 2001 1488 1494
72. H. Jyonouchi, S. Sun, A. Kelly, and F. Rimell Effects of exogenous interferon gamma on patients with treatment resistant chronic rhinosinusitis and dysregulated interferon production Arch Otolaryngol Head Neck Surg 129 2003 563 569
73. J.A. Gollob, K.G. Veenstra, and H. Jyonouchi Impairment of STAT activation by IL-12 in a patient with atypical mycobacterial and staphylococcal infections J Immunol 163 2000 4120 4126
74. N. Remus, J. Reichenbach, and C. Picard Impaired interferon-gamma- mediated immunity and susceptibility to mycobacterial infections in childhood Pediatr Res 50 2001 8 13